[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Surgery Partners CS (SGRY)

Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,864,272
  • Shares Outstanding, K 130,918
  • Annual Sales, $ 3,309 M
  • Annual Income, $ -77,900 K
  • EBIT $ 516 M
  • EBITDA $ 692 M
  • 60-Month Beta 1.91
  • Price/Sales 0.57
  • Price/Cash Flow 8.41
  • Price/Book 0.61

Options Overview Details

View History
  • Implied Volatility 42.10% (-11.10%)
  • Historical Volatility 56.05%
  • IV Percentile 9%
  • IV Rank 17.54%
  • IV High 141.61% on 01/05/26
  • IV Low 20.93% on 09/05/25
  • Expected Move (DTE 1) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.11
  • Today's Volume 251
  • Volume Avg (30-Day) 414
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 15,543
  • Open Int (30-Day) 15,282
  • Expected Range 13.60 to 13.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.02
  • Number of Estimates 1
  • High Estimate $0.02
  • Low Estimate $0.02
  • Prior Year $0.11
  • Growth Rate Est. (year over year) -81.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.58 +0.15%
on 08/19/26
16.64 -18.25%
on 07/30/26
-2.39 (-14.95%)
since 07/17/26
3-Month
13.09 +3.90%
on 05/28/26
17.44 -22.02%
on 07/06/26
-0.09 (-0.66%)
since 05/19/26
52-Week
11.41 +19.19%
on 03/30/26
24.10 -43.57%
on 08/21/25
-9.60 (-41.38%)
since 08/19/25

Most Recent Stories

More News
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call

The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call

SGRY : 13.60 (-4.49%)
1 of Wall Street’s Favorite Stocks to Research Further and 2 We Avoid

1 of Wall Street’s Favorite Stocks to Research Further and 2 We Avoid

PLOW : 41.63 (+0.39%)
SGRY : 13.60 (-4.49%)
LEVI : 22.00 (-0.05%)
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)

Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)

SGRY : 13.60 (-4.49%)
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift

SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift

SGRY : 13.60 (-4.49%)
Surgery Partners: Q2 Earnings Snapshot

Surgery Partners: Q2 Earnings Snapshot

SGRY : 13.60 (-4.49%)
Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations

Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations

SGRY : 13.60 (-4.49%)
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance

BRENTWOOD, Tenn., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today...

SGRY : 13.60 (-4.49%)
Surgery Partners (SGRY) Q2 Earnings: What To Expect

Surgery Partners (SGRY) Q2 Earnings: What To Expect

SGRY : 13.60 (-4.49%)
Surgery Partners Reports Earnings After Bain Rejected Its Independence Argument With Revenue Performance

Barchart Research What to Expect from SGRY Earnings SGRY Generated August 7, 2026 Current Price $15.53 EPS Estimate $$-0.03 Consensus Rating Moderate Buy Average Move 5.38% Surgery Partners Reports Earnings...

SGRY : 13.60 (-4.49%)
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges

1 Profitable Stock for Long-Term Investors and 2 Facing Challenges

ASYS : 14.82 (-12.20%)
NE : 45.87 (+1.37%)
SGRY : 13.60 (-4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment...

See More

Key Turning Points

3rd Resistance Point 15.18
2nd Resistance Point 14.85
1st Resistance Point 14.23
Last Price 13.60
1st Support Level 13.28
2nd Support Level 12.95
3rd Support Level 12.33

See More

52-Week High 24.10
Fibonacci 61.8% 19.25
Fibonacci 50% 17.76
Fibonacci 38.2% 16.26
Last Price 13.60
52-Week Low 11.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.